The target cells of injected type I interferons in mouse liver

被引:4
|
作者
Asada-Kubota, M [1 ]
Tatsumi, R [1 ]
Ueda, T [1 ]
Kobayashi, M [1 ]
Hamada, K [1 ]
Maekawa, S [1 ]
Sokawa, Y [1 ]
机构
[1] Kyoto Inst Technol, Dept Biotechnol, Sakyo Ku, Kyoto 606, Japan
来源
关键词
D O I
10.1089/jir.1998.18.71
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Type I interferons (IFNs) have been used for the treatment of viral hepatitis, but it is unclear which cells in the liver are affected by injected IFN, The effects of IFN have been studied by the production of 2',5'-oligoadenylate synthetase (2'5'OAS), an IFN-inducible enzyme, Here, we studied the distribution of 2'5'OAS in mouse liver after injection of natural mouse IFN-alpha/beta by Western blotting and immunohistochemistry using a monoclonal antibody specific to mouse 42-kDa 2'5'OAS, Injection of IFN-alpha/beta increased the levels of liver 2'5'OAS and enhanced the intensities of immunohistochemical staining for this enzyme in both hepatocytes and Kupffer cells, In IFN-untreated normal mice, hepatocytes were lightly stained, but some of the Kupffer cells showed rather strong staining, The 2'5'OAS-positive Kupffer cells comprised similar to 60% of those in normal liver, whereas this increased to similar to 90% following IFN-alpha/beta injection, Thus, hepatocytes and Kupffer cells were the targets of injected IFN.
引用
收藏
页码:71 / 74
页数:4
相关论文
共 50 条
  • [41] Type I interferons and their antiviral function
    Leroy, M.
    Desmecht, D.
    ANNALES DE MEDECINE VETERINAIRE, 2006, 150 (02) : 73 - 107
  • [42] Type I interferons in infectious disease
    McNab, Finlay
    Mayer-Barber, Katrin
    Sher, Alan
    Wack, Andreas
    O'Garra, Anne
    NATURE REVIEWS IMMUNOLOGY, 2015, 15 (02) : 87 - 103
  • [43] Type I interferons in infectious disease
    Finlay McNab
    Katrin Mayer-Barber
    Alan Sher
    Andreas Wack
    Anne O'Garra
    Nature Reviews Immunology, 2015, 15 : 87 - 103
  • [44] Gene therapy of Type I mucopolysaccharidosis by liver organ stem cells in the mouse model
    Tuysuz, N.
    Koole, W.
    Garcia, T. Martins
    van Til, N.
    Wagemaker, G.
    Huch, M.
    Vries, R. G.
    Clevers, H.
    HUMAN GENE THERAPY, 2014, 25 (11) : A63 - A63
  • [45] Type I interferons produced by dendritic cells promote their phenotypic and functional activation
    Montoya, M
    Schiavoni, G
    Mattei, F
    Gresser, I
    Belardelli, F
    Borrow, P
    Tough, DF
    BLOOD, 2002, 99 (09) : 3263 - 3271
  • [46] Type I interferons enhance production of IFN-gamma by NK cells
    Hunter, CA
    Gabriel, KE
    Radzanowski, T
    Neyer, LE
    Remington, JS
    IMMUNOLOGY LETTERS, 1997, 59 (01) : 1 - 5
  • [47] The Dual Nature of Type I and Type II Interferons
    Lee, Amanda J.
    Ashkar, Ali A.
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [48] Type I interferons are essential mediators of apoptotic death in virally infected cells
    Tanaka, N
    Sato, M
    Lamphier, MS
    Nozawa, H
    Oda, E
    Noguchi, S
    Schreiber, RD
    Tsujimoto, Y
    Taniguchi, T
    GENES TO CELLS, 1998, 3 (01) : 29 - 37
  • [49] Multiple effects of immunostimulatory DNA on T cells and the role of type I interferons
    Sun, SQ
    Zhang, XH
    Tough, D
    Sprent, J
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 2000, 22 (1-2): : 77 - 84
  • [50] Type I interferons and SARS-CoV-2: from cells to organisms
    Bastard, Paul
    Zhang, Qian
    Zhang, Shen-Ying
    Jouanguy, Emmanuelle
    Casanova, Jean-Laurent
    CURRENT OPINION IN IMMUNOLOGY, 2022, 74 : 172 - 182